SARTORIUS AG (SRT.DE) Stock Fundamental Analysis
FRA:SRT - Deutsche Boerse Ag - DE0007165607 - Common Stock - Currency: EUR
SRT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of SRT have multiple concerns. SRT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SRT was profitable.
In the past year SRT had a positive cash flow from operations.
Each year in the past 5 years SRT has been profitable.
In the past 5 years SRT always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 1.04%, SRT is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
SRT has a Return On Equity of 3.92%. This is in the lower half of the industry: SRT underperforms 66.67% of its industry peers.
The Return On Invested Capital of SRT (3.80%) is worse than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SRT is in line with the industry average of 6.95%.
The last Return On Invested Capital (3.80%) for SRT is well below the 3 year average (8.34%), which needs to be investigated, but indicates that SRT had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.04% | ||
| ROE | 3.92% | ||
| ROIC | 3.8% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
SRT has a Profit Margin of 3.00%. This is in the lower half of the industry: SRT underperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of SRT has declined.
SRT has a Operating Margin of 12.48%. This is in the lower half of the industry: SRT underperforms 61.11% of its industry peers.
In the last couple of years the Operating Margin of SRT has declined.
SRT has a Gross Margin of 45.76%. This is in the better half of the industry: SRT outperforms 77.78% of its industry peers.
In the last couple of years the Gross Margin of SRT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.48% | ||
| PM (TTM) | 3% | ||
| GM | 45.76% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SRT is still creating some value.
The number of shares outstanding for SRT has been increased compared to 1 year ago.
SRT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SRT has an improved debt to assets ratio.
2.2 Solvency
SRT has an Altman-Z score of 1.81. This is a bad value and indicates that SRT is not financially healthy and even has some risk of bankruptcy.
SRT has a Altman-Z score of 1.81. This is in the lower half of the industry: SRT underperforms 66.67% of its industry peers.
SRT has a debt to FCF ratio of 8.09. This is a slightly negative value and a sign of low solvency as SRT would need 8.09 years to pay back of all of its debts.
The Debt to FCF ratio of SRT (8.09) is worse than 61.11% of its industry peers.
A Debt/Equity ratio of 1.54 is on the high side and indicates that SRT has dependencies on debt financing.
With a Debt to Equity ratio value of 1.54, SRT is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.54 | ||
| Debt/FCF | 8.09 | ||
| Altman-Z | 1.81 |
ROIC/WACC0.55
WACC6.92%
2.3 Liquidity
A Current Ratio of 1.39 indicates that SRT should not have too much problems paying its short term obligations.
SRT's Current ratio of 1.39 is on the low side compared to the rest of the industry. SRT is outperformed by 61.11% of its industry peers.
SRT has a Quick Ratio of 1.39. This is a bad value and indicates that SRT is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT's Quick ratio of 0.88 is on the low side compared to the rest of the industry. SRT is outperformed by 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 33.21% over the past year.
Measured over the past years, SRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.87% on average per year.
SRT shows a small growth in Revenue. In the last year, the Revenue has grown by 3.80%.
The Revenue has been growing by 13.10% on average over the past years. This is quite good.
EPS 1Y (TTM)33.21%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%7.02%
Revenue 1Y (TTM)3.8%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%2.74%
3.2 Future
The Earnings Per Share is expected to grow by 19.27% on average over the next years. This is quite good.
SRT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.50% yearly.
EPS Next Y22.89%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
EPS Next 5Y19.27%
Revenue Next Year5.64%
Revenue Next 2Y7.36%
Revenue Next 3Y8.73%
Revenue Next 5Y8.5%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 34.25, which means the current valuation is very expensive for SRT.
61.11% of the companies in the same industry are cheaper than SRT, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.48, SRT is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 23.48, the valuation of SRT can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as SRT.
SRT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.25 | ||
| Fwd PE | 23.48 |
4.2 Price Multiples
SRT's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRT indicates a somewhat cheap valuation: SRT is cheaper than 72.22% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.39 | ||
| EV/EBITDA | 17.41 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as SRT's earnings are expected to grow with 26.21% in the coming years.
PEG (NY)1.5
PEG (5Y)N/A
EPS Next 2Y24.43%
EPS Next 3Y26.21%
5. Dividend
5.1 Amount
With a yearly dividend of 0.49%, SRT is not a good candidate for dividend investing.
The stock price of SRT dropped by -20.06% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
SRT's Dividend Yield is comparable with the industry average which is at 0.73.
Compared to an average S&P500 Dividend Yield of 2.39, SRT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.49% |
5.2 History
The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
48.70% of the earnings are spent on dividend by SRT. This is a bit on the high side, but may be sustainable.
The dividend of SRT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.7%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
FRA:SRT (8/8/2025, 7:00:00 PM)
149
+0.4 (+0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.16B
Analysts77.14
Price Target272.34 (82.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.49% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP48.7%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.33%
Min EPS beat(2)-10.52%
Max EPS beat(2)-4.13%
EPS beat(4)0
Avg EPS beat(4)-10.28%
Min EPS beat(4)-22.4%
Max EPS beat(4)-4.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.97%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)2.67%
Revenue beat(4)2
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-4.07%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.7%
PT rev (3m)-0.7%
EPS NQ rev (1m)-13.25%
EPS NQ rev (3m)-10.74%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-4.15%
Revenue NQ rev (3m)-3.54%
Revenue NY rev (1m)-0.69%
Revenue NY rev (3m)-0.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.25 | ||
| Fwd PE | 23.48 | ||
| P/S | 3.22 | ||
| P/FCF | 19.39 | ||
| P/OCF | 12.14 | ||
| P/B | 4.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.41 |
EPS(TTM)4.35
EY2.92%
EPS(NY)6.35
Fwd EY4.26%
FCF(TTM)7.68
FCFY5.16%
OCF(TTM)12.27
OCFY8.24%
SpS46.31
BVpS35.5
TBVpS-35.06
PEG (NY)1.5
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.04% | ||
| ROE | 3.92% | ||
| ROCE | 5.11% | ||
| ROIC | 3.8% | ||
| ROICexc | 4.21% | ||
| ROICexgc | 13.6% | ||
| OM | 12.48% | ||
| PM (TTM) | 3% | ||
| GM | 45.76% | ||
| FCFM | 16.59% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexcg growth 3Y-35.26%
ROICexcg growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.54 | ||
| Debt/FCF | 8.09 | ||
| Debt/EBITDA | 4.76 | ||
| Cap/Depr | 80.56% | ||
| Cap/Sales | 9.91% | ||
| Interest Coverage | 2.25 | ||
| Cash Conversion | 106.92% | ||
| Profit Quality | 552.64% | ||
| Current Ratio | 1.39 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 1.81 |
F-Score7
WACC6.92%
ROIC/WACC0.55
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)33.21%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%7.02%
EPS Next Y22.89%
EPS Next 2Y24.43%
EPS Next 3Y26.21%
EPS Next 5Y19.27%
Revenue 1Y (TTM)3.8%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%2.74%
Revenue Next Year5.64%
Revenue Next 2Y7.36%
Revenue Next 3Y8.73%
Revenue Next 5Y8.5%
EBIT growth 1Y1.03%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year103.14%
EBIT Next 3Y38.58%
EBIT Next 5Y26.99%
FCF growth 1Y187.94%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y14.51%
OCF growth 3Y4.07%
OCF growth 5Y20.79%